Navigation Links
BioDrain Announces First Quarter 2013 Results
Date:5/15/2013

MINNEAPOLIS, May 15, 2013 /PRNewswire/ -- BioDrain Medical, Inc. (OTCQB: BIOR) (the "Company"), producer of the FDA approved STREAMWAY System for automated, direct-to-drain surgical fluid disposal that reduces the risk of exposure to hazardous waste, today reported its results for the first quarter ended March 31, 2013.

Key Highlights:

  • Revenues of $127,727 for Q1 2013 were up over 450% compared to Q1 2012
  • Sales to operating rooms, surgical centers and hospital systems in new geographies have expanded BioDrain's presence in the surgical waste fluid management industry
  • Purchase order and trial unit for the first quarter exceed 20 STREAMWAY Systems
  • Revenues for the first quarter of 2013 were $127,727, up over 450% compared to $22,635 for the same period in 2012. Gross profit for the first quarter of 2013 was $86,123, nearly a 10-fold increase from $8,829 for the same period in 2012.

    Net loss for the period was ($2.1) million, or ($0.02) per diluted share, compared to net loss of ($713,367), or ($0.02) per diluted share, in the comparable period in 2012. The increased loss resulted in part from increased stock compensation costs due to stock option valuations for the first quarter, as well as an increase in investor stock compensation, a method of remuneration to an investor in lieu of cash equity financing raised as the Company ramps up production to meet second and third quarter demand. BioDrain CEO, Josh Kornberg , emphasized, "We have proposed additional small financing to allow us to further our production capability to meet market demand."

    Mr. Kornberg continued, "BioDrain had a great first quarter in 2013. Not only do we have a robust new business pipeline that includes numerous hospital networks and surgical centers, but in the past several weeks we have added new installations and ex
    '/>"/>

    SOURCE BioDrain Medical, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. BioDrain Medical Exhibits at National Registered Nurses Conference
    2. BioDrain Medical Retains KCSA Strategic Communications as Corporate Communications Counsel
    3. BioDrain Medical Inc. Signs Additional Independent Distribution Agreements, Strengthening Nationwide Presence
    4. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
    5. International Isotopes Inc. Announces First Quarter 2013 Financial Results
    6. Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
    7. Concord Medical Announces the Signing of US$50 Million IFC Loan Agreement
    8. The Law Offices of Marc S. Henzel Announces Class Action Lawsuit Against Aveo Pharmaceuticals, Inc. and Certain Officers -- (Nasdaq: AVEO) was filed on behalf of stockholders
    9. Heska Announces Financial Results for the First Quarter of Fiscal 2013
    10. DEACOM ERP Announces MRO Module for Process and Mixed Mode Manufacturing Companies
    11. Natural Alternatives International, Inc. Announces Fiscal 2013 Q3 and YTD Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced ... have been enrolled into the Company,s Phase 2 clinical ... safety of Gem,s lead compound, GPX-150 (an investigational medication), ... or metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
    (Date:1/22/2015)... 22, 2015  BiOptix is pleased to announce the appointment ... of Chemistry and Biochemistry. Scott joins the company after previous ... Amgen throughout the course of his nearly 20 year ... is a nationally recognized thought leader in the biosensor ...
    (Date:1/22/2015)... , Jan. 22, 2015  Amgen (NASDAQ: AMGN ) today ... 2014 financial results on Tuesday, Jan. 27, 2015, after the close ... a conference call with the investment community at 2 p.m. PT. ... Bradway , chairman and chief executive officer, and other members of ...
    Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
    ... and MTA:CTIC) (the "Company") today announced that it has entered ... $30 million of shares of its Series 13 Preferred Stock ... a registered offering to six institutional investors. Each share of ... the holder, at any time during its existence, into approximately ...
    ... June 29, 2011 NxStage® Medical, Inc. (Nasdaq: ... products, announced that it has entered into a new ... its corporate headquarters to the revitalized historic mill complex ... Lawrence, MA.  The move, which is expected to be ...
    Cached Medicine Technology:Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants 2Cell Therapeutics, Inc. Announces Institutional Investors Purchase $30 Million of Preferred Stock and Warrants 3NxStage® Enters Into New Lease for Corporate Headquarters Within Lawrence, MA 2
    (Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
    (Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
    (Date:1/22/2015)... released a new blog post presenting the basic features of ... an accidental death and dismemberment rider for a car insurance ... benefits if the insured dies in an accident. Accidental death ... insurance. , AD&D is not expensive and can be ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 Yesterday, ... Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were honored ... leadership in advancing biotechnology, biomedical science, medical device ... Olsen each received the “2014 Life Sciences Champion” ...
    (Date:1/22/2015)... Four years since the release of their debut recording Love is ... Avasa & Matthew Love – the duo are pleased to announce ... White Swan Records on February 24, 2015. , THE ROAD offers ... to all of us to walk out of the mire of ...
    Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
    ... According to a survey done by the U.S. government it was ... among the America's elderly population//. It is said that adults aged ... estimated that the number of people addicted to drug would double ... generation is addicted to drugs due to problems such as pain, ...
    ... Drug addiction is becoming a significant public health probelm ... that the number of individuals with drug addiction// problems ... of 2020. ,Nearly 2.5 million Americans have ... 1999. The increasing inclination of elders to take drugs ...
    ... collaborate to prove through clinical trials the efficacy of ... known to cure but for which there is no ... collaboration has been approved by the board members and ... to the government for seeking funding," said Ranjit Roy ...
    ... has confirmed five more bird flu related deaths in Indonesia, ... team has further been sent to the northern Sumatra region, ... same family) had lived. The fifth victim was a 38-year-old ... and meat. ,,It is further suspected that eight ...
    ... helps to protect the lungs of premature infants from ... McMaster University researchers have reported// an early finding in ... caffeine therapy for the treatment of apnoea of prematurity. ... preterm infants, because the lungs are underdeveloped and the ...
    ... will not be allowed to make tall claims on their ... EU lawmakers have clamped down on misleading claims or health ... to set a common standard for vitamins, minerals and food ... manufacturers who are not able to justify their claims will ...
    Cached Medicine News:Health News:Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs 2Health News:Indian And Chinese Doctors Join Together To Prove The Efficacy Of Herbal Drugs 3Health News:Caffeine Therapy May Help Protect Lungs Of Premature Babies 2
    ... continuous random access analyzer with a ... hour, has been designed specifically for ... and high-volume laboratories. The IMMULITE 2000 ... user interface, offers streamlined information management, ...
    ... Vidas is an automated, ... designed testing device stores the ... thus optimizing the cost-per-patient result. ... minimum maintenance, ease of use ...
    ... automated random access immunoassay testing, comes the AIA-600 ... proven reliability of Tosohs original AIA-600, is loaded ... and continuous process operation., Test Menu: ... FT3 FT4 T-Uptake TSH 3rd ...
    ... The Vitros ECi brings true automation ... immunodiagnostic testing. Highly sensitive assays for ... and bone metabolism testing are currently ... development. The Vitros ECi can simultaneously ...
    Medicine Products: